Masmoudi Abderrahmen, Hajjaji Darouiche Mounira, Ben Salah Haifa, Ben Hmida Mohamed, Turki Hamida
Department of Dermatology, Hedi Chaker Hospital, Sfax, Tunisia;
Department of Nephrology, Hedi Chaker Hospital, Sfax, Tunisia.
J Dermatol Case Rep. 2014 Dec 31;8(4):86-94. doi: 10.3315/jdcr.2014.1182.
Cutaneous manifestations occurring in patients with end stage renal failure on hemodialysis are polymorphic and diverse.
The aim of our study was to assess the prevalence and characteristics of different cutaneous manifestations in patients on hemodialysis.
We led a transverse investigation of all patients on hemodialysis in 12 haemodialysis centres of Sfax (Tunisia). We examined 458 patients (254 men and 204 women). The hemodialysis history ranged from 6 months to 24 years. A total of 394/458 (86%) patients had cutaneous abnormalities. These included pruritus (56.6% of patients), paleness (60.7%), xerosis (52.8%), hyperpigmentation or hypopigmentation (38.4%), venous dilation near the fistula (22.2%), eczema in the fistula area (14.8%), half-and-half nails (13.5%), onychodystrophy (6.1%), subungual hemorrhage (4.5%), leukonychia (4.5%), stomatitis (5.6%), xerostomia (3.2%), gingivitis (2.4%), uremic breath (2.1%), and skin calcificatins (0.4%). Nephrogenic fibrosing dermopathy was not detected in any of our patients.
Pruritus, paleness, dry skin as well as hyperpigmentation and hypopigmentation are the most frequent skin abnormalities observed in hemodialysis patients. The early recognition of some cutaneous conditions associated with end stage renal failure and hemodialysis may allow early therapeutic intervention and decrease morbidity.
终末期肾衰竭患者在血液透析过程中出现的皮肤表现具有多形性且多种多样。
我们研究的目的是评估血液透析患者中不同皮肤表现的患病率及特征。
我们对突尼斯斯法克斯12个血液透析中心的所有血液透析患者进行了一项横断面调查。我们检查了458例患者(254例男性和204例女性)。血液透析病史从6个月至24年不等。共有394/458(86%)例患者存在皮肤异常。这些异常包括瘙痒(56.6%的患者)、面色苍白(60.7%)、皮肤干燥(52.8%)、色素沉着或色素减退(38.4%)、瘘管附近静脉扩张(22.2%)、瘘管部位湿疹(14.8%)、对半甲(13.5%)、甲营养不良(6.1%)、甲下出血(4.5%)、白甲(4.5%)、口腔炎(5.6%)、口干(3.2%)、牙龈炎(2.4%)、尿毒症口臭(2.1%)以及皮肤钙化(0.4%)。在我们的任何患者中均未检测到肾源性纤维化皮肤病。
瘙痒、面色苍白、皮肤干燥以及色素沉着和色素减退是血液透析患者中最常见的皮肤异常。对一些与终末期肾衰竭和血液透析相关的皮肤状况的早期识别可能有助于早期治疗干预并降低发病率。